We are disheartened to learn of the revelations in Sunday’s “60 Minutes” story. The story revealed lobbying on behalf of pharmaceutical distributors to limit the authority of the Drug Enforcement Administration (DEA) to investigate and prosecute illegal shipments of opioids being diverted to small communities.
Statement from Fred Muench, Partnership President and CEO, in Response to “60 Minutes” Feature
We are disheartened to learn of the revelations in Sunday’s “60 Minutes” story. The story revealed lobbying on behalf of pharmaceutical distributors to limit the authority of the Drug Enforcement Administration (DEA) to investigate and prosecute illegal shipments of opioids being diverted to small communities.
Published
October 2017